PACIFIC Subgroup Analysis: Pneumonitis in Stage III, Unresectable NSCLC Patients Treated with Durvalumab vs. Placebo After CRT


Creative Commons License

Vansteenkiste J., Naidoo J., Faivre-Finn C., Ozguroglu M., Villegas A., Daniel D., ...Daha Fazla

JOURNAL OF THORACIC ONCOLOGY, cilt.13, sa.10, 2018 (SCI-Expanded, Scopus) identifier